Mats Erntell

1.4k total citations
21 papers, 985 citations indexed

About

Mats Erntell is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Mats Erntell has authored 21 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 8 papers in Epidemiology and 6 papers in Applied Microbiology and Biotechnology. Recurrent topics in Mats Erntell's work include Streptococcal Infections and Treatments (9 papers), Antibiotic Use and Resistance (6 papers) and Pneumonia and Respiratory Infections (5 papers). Mats Erntell is often cited by papers focused on Streptococcal Infections and Treatments (9 papers), Antibiotic Use and Resistance (6 papers) and Pneumonia and Respiratory Infections (5 papers). Mats Erntell collaborates with scholars based in Sweden, United Kingdom and Belgium. Mats Erntell's co-authors include Erling B. Myhre, Cecilia Stålsby Lundborg, Faranak Ansari, Peter Davey, Herman Goossens, Ingeborg Björkman, Marta Röing, Håkan Hanberger, Otto Cars and Gunilla Skoog and has published in prestigious journals such as Clinical Infectious Diseases, The Lancet Infectious Diseases and Bulletin of the World Health Organization.

In The Last Decade

Mats Erntell

21 papers receiving 954 citations

Peers

Mats Erntell
Dag Berild Norway
Se Yoon Park South Korea
Rajeshwari Nair United States
Lindsay A Petty United States
Micaela Gal United Kingdom
Sarah B. Doernberg United States
Matthew S. Simon United States
Christopher M. Bland United States
Dag Berild Norway
Mats Erntell
Citations per year, relative to Mats Erntell Mats Erntell (= 1×) peers Dag Berild

Countries citing papers authored by Mats Erntell

Since Specialization
Citations

This map shows the geographic impact of Mats Erntell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Erntell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Erntell more than expected).

Fields of papers citing papers by Mats Erntell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Erntell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Erntell. The network helps show where Mats Erntell may publish in the future.

Co-authorship network of co-authors of Mats Erntell

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Erntell. A scholar is included among the top collaborators of Mats Erntell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Erntell. Mats Erntell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mölstad, Sigvard, Sonja Löfmark, Mats Erntell, et al.. (2017). Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bulletin of the World Health Organization. 95(11). 764–773. 132 indexed citations
2.
Skoog, Gunilla, Johan Struwe, Otto Cars, et al.. (2016). Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003–2010. Eurosurveillance. 21(25). 23 indexed citations
3.
Cars, Otto, et al.. (2012). [National recommendations for the treatment of pharyngotonsillitis are valid].. PubMed. 109(3). 108–9. 1 indexed citations
4.
Linde, Annika, et al.. (2012). [Health personnel the key to high vaccination coverage against influenza].. PubMed. 109(1-2). 8–9. 1 indexed citations
5.
Björkman, Ingeborg, Mats Erntell, Marta Röing, & Cecilia Stålsby Lundborg. (2011). Infectious disease management in primary care: perceptions of GPs. BMC Family Practice. 12(1). 1–1. 107 indexed citations
6.
Björkman, Ingeborg, Johanna Berg, Marta Röing, Mats Erntell, & Cecilia Stålsby Lundborg. (2010). Perceptions among Swedish hospital physicians on prescribing of antibiotics and antibiotic resistance. BMJ Quality & Safety. 19(6). e8–e8. 42 indexed citations
7.
Söderblom, Tomas, Olov Aspevall, Mats Erntell, et al.. (2010). Alarming spread of vancomycin resistant enterococci in Sweden since 2007. Eurosurveillance. 15(29). 34 indexed citations
8.
Ansari, Faranak, Mats Erntell, Herman Goossens, & Peter Davey. (2009). The European Surveillance of Antimicrobial Consumption (ESAC) Point‐Prevalence Survey of Antibacterial Use in 20 European Hospitals in 2006. Clinical Infectious Diseases. 49(10). 1496–1504. 182 indexed citations
9.
Mölstad, Sigvard, Mats Erntell, Håkan Hanberger, et al.. (2008). Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. The Lancet Infectious Diseases. 8(2). 125–132. 188 indexed citations
10.
Erntell, Mats, Fazel Ansari, Herman Goossens, & P Davey. (2007). O166 ESAC II Hospital Care Subproject 2005–2007: patterns of antibiotic use in relation to diagnoses in 19 European hospitals in 2006, Point Prevalence Study. International Journal of Antimicrobial Agents. 29. S33–S33. 1 indexed citations
11.
Château, Maarten de, Bo Nilson, Mats Erntell, et al.. (1993). On the Interaction between Protein L and Immunoglobulins of Various Mammalian Species. Scandinavian Journal of Immunology. 37(4). 399–405. 60 indexed citations
12.
Erntell, Mats, et al.. (1989). Erythema nodosum—a Manifestation of Chlamydia pneumoniae (strain TWAR) Infection. Scandinavian Journal of Infectious Diseases. 21(6). 693–696. 16 indexed citations
13.
Erntell, Mats, et al.. (1988). Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG. Molecular Immunology. 25(2). 121–126. 57 indexed citations
14.
Erntell, Mats, Erling B. Myhre, Ulf Sjöbring, & Göran Kronvall. (1988). Non‐immune Fab‐ and Fc‐ mediated interactions of avian Ig with S. aureus and group C and G streptococci. Apmis. 96(1-6). 239–249. 6 indexed citations
15.
Erntell, Mats, S. Holtås, Karin Norlin, Erik Dahlquist, & I. Nilsson-Ehle. (1988). Magnetic Resonance Imaging in the Diagnosis of Spinal Epidural Abscess. Scandinavian Journal of Infectious Diseases. 20(3). 323–327. 34 indexed citations
16.
Erntell, Mats, Erling B. Myhre, & Göran Kronvall. (1986). NON‐IMMUNE F(ab‘)2‐ AND Fc‐MEDIATED INTERACTIONS OF MAMMALIAN IMMUNOGLOBULINS WITH S. AUREUS AND GROUP C AND G STREPTOCOCCI. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 94B(1-6). 377–385. 14 indexed citations
17.
Erntell, Mats, Erling B. Myhre, & Göran Kronvall. (1986). TWO SEPARATE NON‐IMMUNE INTERACTIONS BETWEEN STAPHYLOCOCCAL PROTEIN A AND IMMUNOGLOBULINS ARE MEDIATED BY STRUCTURES ON γ CHAINS. Acta Pathologica Microbiologica Scandinavica Series B Microbiology. 94B(1-6). 69–73. 6 indexed citations
18.
Myhre, Erling B. & Mats Erntell. (1985). A non-immune interaction between the light chain of human immunoglobulin and a surface component of a Peptococcus magnus strain. Molecular Immunology. 22(8). 879–885. 34 indexed citations
19.
Erntell, Mats, Erling B. Myhre, & G Kronvall. (1985). Non‐Immune IgG F(ab′)2 Binding to Group C and G Streptococci Is Mediated by Structures on γ Chains. Scandinavian Journal of Immunology. 21(2). 151–157. 18 indexed citations
20.
Erntell, Mats, Erling B. Myhre, & G Kronvall. (1983). Alternative Non‐Immune F(ab')2‐Mediated Immunoglobulin Binding to Group C and G Streptococci. Scandinavian Journal of Immunology. 17(3). 201–209. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026